WallStreetZenWallStreetZen

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
ARVN
ARVINAS INC
NASDAQ
Biotechnology
$2.22B$32.37-5.71%-$346.70M-5.35x0.99
SDGR
SCHRODINGER INC
NASDAQ
Health Information Services
$1.69B$23.22-2.11%-$151.70M-11.67x0.44
LFST
LIFESTANCE HEALTH GROUP INC
NASDAQ
Medical Care Facilities
$2.66B$6.980.00%-$64.94M-13.69x0.48
LQDA
LIQUIDIA CORP
NASDAQ
Biotechnology
$950.35M$12.50-2.65%-$69.65M-10.33x1.50
OPRX
OPTIMIZERX CORP
NASDAQ
Health Information Services
$192.75M$10.60-1.76%-$21.31M-10.29x0.45
NRBO
NEUROBO PHARMACEUTICALS INC
NASDAQ
Biotechnology
$19.28M$3.932.34%-$12.46M-1.60x0.37
EMBC
EMBECTA CORP
NASDAQ
Medical Instruments & Supplies
$591.34M$10.27-2.65%$207.60M10.70x-2.54
QURE
UNIQURE NV
NASDAQ
Biotechnology
$237.41M$4.891.45%-$226.99M-0.79x4.25
DNLI
DENALI THERAPEUTICS INC
NASDAQ
Biotechnology
$2.70B$18.9012.17%-$128.37M-20.32x0.09
OTRK
ONTRAK INC
NASDAQ
Health Information Services
$12.44M$0.26-1.88%-$14.42M-0.08x0.39
CLDX
CELLDEX THERAPEUTICS INC
NASDAQ
Biotechnology
$2.72B$41.21-2.37%-$141.82M-14.41x0.04
PDEX
PRO DEX INC
NASDAQ
Medical Instruments & Supplies
$63.94M$18.704.47%$7.57M15.20x0.63
LYEL
LYELL IMMUNOPHARMA INC
NASDAQ
Biotechnology
$637.35M$2.50-1.57%-$208.09M-2.78x0.15
LYRA
LYRA THERAPEUTICS INC
NASDAQ
Biotechnology
$23.78M$0.39-7.14%-$68.69M-0.33x0.83
CUE
CUE BIOPHARMA INC
NASDAQ
Biotechnology
$92.91M$1.91-12.39%-$46.05M-1.72x0.66
IGMS
IGM BIOSCIENCES INC
NASDAQ
Biotechnology
$551.28M$9.34-5.94%-$222.04M-2.18x1.33
BNGO
BIONANO GENOMICS INC
NASDAQ
Medical Instruments & Supplies
$61.51M$0.92-3.87%-$207.91M-0.15x0.91
CODX
CO-DIAGNOSTICS INC
NASDAQ
Medical Devices
$38.14M$1.22-3.17%-$36.83M-1.02x0.11
ARDX
ARDELYX INC
NASDAQ
Biotechnology
$1.98B$8.48-8.92%-$53.48M-29.24x1.27
SRTS
SENSUS HEALTHCARE INC
NASDAQ
Medical Devices
$62.79M$3.831.32%$1.11M127.67x0.10
SPRC
SCISPARC LTD
NASDAQ
Biotechnology
$876.29k$1.242.48%$1.80M-0.32x0.21
XOMA
XOMA CORP
NASDAQ
Biotechnology
$281.34M$24.20-1.31%-$39.24M-5.99x1.64
PINC
PREMIER INC
NASDAQ
Health Information Services
$2.06B$19.611.03%$246.87M30.17x0.75
NPCE
NEUROPACE INC
NASDAQ
Medical Devices
$362.48M$12.60-5.26%-$21.06M-10.68x5.89
KROS
KEROS THERAPEUTICS INC
NASDAQ
Biotechnology
$2.10B$58.24-0.75%-$158.01M-11.31x0.07
QTTB
Q32 BIO INC
NASDAQ
Biotechnology
$84.87M$26.28-3.35%-$110.32M-0.75x0.16
RVMD
REVOLUTION MEDICINES INC
NASDAQ
Biotechnology
$6.32B$38.31-1.47%-$477.95M-10.03x0.11
OLK
OLINK HOLDING AB (PUBL)
NASDAQ
Diagnostics & Research
$2.92B$23.471.08%-$20.05M-93.88x0.20
PRTC
PURETECH HEALTH PLC
NASDAQ
Biotechnology
$746.51M$27.460.00%-$30.24M-11.44x0.51
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA INC
NASDAQ
Medical Devices
$450.16M$1.68-10.16%-$277.28M-1.39x1.49
PLRX
PLIANT THERAPEUTICS INC
NASDAQ
Biotechnology
$808.97M$13.41-2.76%-$164.98M-4.67x0.19
INO
INOVIO PHARMACEUTICALS INC
NASDAQ
Biotechnology
$257.07M$11.00-1.35%-$130.39M-1.81x0.46
WRBY
WARBY PARKER INC
NYSE
Medical Instruments & Supplies
$1.47B$12.44-1.74%-$30.55M-23.04x0.92
IKNA
IKENA ONCOLOGY INC
NASDAQ
Biotechnology
$66.11M$1.37-2.84%-$65.59M-0.84x0.13
IFRX
INFLARX NV
NASDAQ
Biotechnology
$70.66M$1.20-3.23%-$43.72M-1.55x0.13
PRCT
PROCEPT BIOROBOTICS CORP
NASDAQ
Medical Devices
$3.10B$60.36-3.87%-$95.59M-28.47x0.45
HCA
HCA HEALTHCARE INC
NYSE
Medical Care Facilities
$81.04B$309.42-1.60%$12.24B15.22x-34.48
LIFE
ATYR PHARMA INC
NASDAQ
Biotechnology
$116.63M$1.69-0.59%-$51.17M-1.88x0.34
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
NASDAQ
Biotechnology
$6.01M$4.43-3.70%-$5.19M-1.18x0.04
OCS
OCULIS HOLDING AG
NASDAQ
Biotechnology
$454.48M$12.37-2.14%N/A-7.46x0.25
ARQT
ARCUTIS BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$773.54M$7.991.40%-$227.43M-2.11x2.85
PLUR
PLURI INC
NASDAQ
Biotechnology
$30.44M$5.87-0.34%-$21.99M-1.27x7.94
ALLO
ALLOGENE THERAPEUTICS INC
NASDAQ
Biotechnology
$466.69M$2.76-5.15%-$313.07M-1.32x0.26
IMNM
IMMUNOME INC
NASDAQ
Biotechnology
$937.20M$15.702.41%-$106.08M-2.92x0.24
MIST
MILESTONE PHARMACEUTICALS INC
NASDAQ
Biotechnology
$90.35M$1.70-2.30%-$57.04M-1.22x3.49
AMS
AMERICAN SHARED HOSPITAL SERVICES
NYSEMKT
Medical Care Facilities
$19.31M$3.05-1.29%$7.28M30.50x0.97
DRIO
DARIOHEALTH CORP
NASDAQ
Diagnostics & Research
$47.40M$1.61-1.23%-$54.38M-0.83x0.66
NTLA
INTELLIA THERAPEUTICS INC
NASDAQ
Biotechnology
$2.21B$23.00-3.69%-$472.22M-4.24x0.24
PGEN
PRECIGEN INC
NASDAQ
Biotechnology
$331.06M$1.33-3.62%-$89.23M-3.41x0.28
SXTP
60 DEGREES PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.53M$0.228.42%-$1.38M-0.22x0.61
PPBT
PURPLE BIOTECH LTD
NASDAQ
Biotechnology
$10.91M$0.557.84%$22.27MN/A0.29
EOLS
EVOLUS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$830.22M$13.26-1.19%-$38.05M-12.75x11.26
CVKD
CADRENAL THERAPEUTICS INC
NASDAQ
Biotechnology
$7.86M$0.492.29%-$8.34M-0.79x0.11
CTMX
CYTOMX THERAPEUTICS INC
NASDAQ
Biotechnology
$326.48M$4.192.95%$26.34M20.95x-6.83
GHSI
GUARDION HEALTH SCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$10.41M$8.112.66%$177.45k67.58x0.46
COCP
COCRYSTAL PHARMA INC
NASDAQ
Biotechnology
$16.33M$1.612.23%-$17.16M-0.86x0.19
OVID
OVID THERAPEUTICS INC
NASDAQ
Biotechnology
$218.49M$3.093.00%-$50.74M-4.18x0.64
HSDT
HELIUS MEDICAL TECHNOLOGIES INC
NASDAQ
Medical Devices
$1.59M$1.79-0.56%-$8.89M-0.12x2.27
KYMR
KYMERA THERAPEUTICS INC
NASDAQ
Biotechnology
$2.36B$38.500.16%-$150.23M-15.34x0.22
AADI
AADI BIOSCIENCE INC
NASDAQ
Biotechnology
$45.18M$1.84-12.80%-$67.96M-0.72x0.23
CRNX
CRINETICS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$3.54B$50.896.78%-$212.22M-13.79x0.18
UFPT
UFP TECHNOLOGIES INC
NASDAQ
Medical Devices
$1.93B$251.94-0.43%$68.95M42.77x0.41
IMAB
I-MAB
NASDAQ
Biotechnology
$144.53M$1.79-1.65%-$195.33M-0.73x0.52
SMTI
SANARA MEDTECH INC
NASDAQ
Medical Instruments & Supplies
$283.35M$32.86-1.91%$190.58k-63.19x0.65
PALI
PALISADE BIO INC
NASDAQ
Biotechnology
$6.01M$7.06-10.63%-$12.20M-0.26x0.24
BMY
BRISTOL MYERS SQUIBB CO
NYSE
Drug Manufacturers - General
$88.52B$43.67-0.84%$4.00B-14.13x5.00
HCAT
HEALTH CATALYST INC
NASDAQ
Health Information Services
$389.44M$6.65-1.92%-$81.68M-3.18x0.91
ALPN
ALPINE IMMUNE SCIENCES INC
NASDAQ
Biotechnology
$4.24B$64.700.09%-$31.41M-101.09x0.16
NGNE
NEUROGENE INC
NASDAQ
Biotechnology
$422.86M$32.90-3.06%-$32.35M1.19x0.20
LUMO
LUMOS PHARMA INC
NASDAQ
Biotechnology
$24.32M$3.00-0.66%-$34.02M-0.72x0.49
MRNA
MODERNA INC
NASDAQ
Biotechnology
$46.71B$121.890.68%-$4.22B-7.78x0.31
GERN
GERON CORP
NASDAQ
Biotechnology
$2.26B$3.81-1.55%-$190.52M-10.89x0.40
EDIT
EDITAS MEDICINE INC
NASDAQ
Biotechnology
$414.07M$5.04-11.36%-$179.30M-2.42x0.50
GBIO
GENERATION BIO CO
NASDAQ
Biotechnology
$206.08M$3.10-2.52%-$121.35M-1.58x0.85
IART
INTEGRA LIFESCIENCES HOLDINGS CORP
NASDAQ
Medical Devices
$1.96B$24.91-0.68%$222.98M48.84x1.55
FUSN
FUSION PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.82B$21.400.00%-$93.51M-15.07x0.34
MGNX
MACROGENICS INC
NASDAQ
Biotechnology
$915.25M$14.66-8.66%$5.51M-97.73x0.96
OGN
ORGANON & CO
NYSE
Drug Manufacturers - General
$5.24B$20.37-0.15%$1.44B4.97x246.73
NRC
NATIONAL RESEARCH CORP
NASDAQ
Health Information Services
$709.91M$29.76-16.47%$46.72M23.62x1.50
SLRN
ACELYRIN INC
NASDAQ
Biotechnology
$471.17M$4.793.68%-$381.37M-0.88x0.13
PAHC
PHIBRO ANIMAL HEALTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$695.85M$17.182.44%$79.80M52.06x2.63
ABSI
ABSCI CORP
NASDAQ
Biotechnology
$557.16M$4.94-1.20%-$95.46M-4.12x0.23
AKRO
AKERO THERAPEUTICS INC
NASDAQ
Biotechnology
$1.18B$21.02-4.54%-$148.40M-7.27x0.08
TWST
TWIST BIOSCIENCE CORP
NASDAQ
Diagnostics & Research
$2.41B$41.40-4.01%-$155.32M-12.32x0.26
TERN
TERNS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$391.14M$6.055.03%-$89.09M-4.76x0.05
BOLT
BOLT BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$42.32M$1.112.78%-$64.39M-0.61x0.42
BPMC
BLUEPRINT MEDICINES CORP
NASDAQ
Biotechnology
$6.81B$108.780.21%-$246.69M-22.85x2.34
PMCB
PHARMACYTE BIOTECH INC
NASDAQ
Biotechnology
$18.28M$2.162.37%-$1.14M-1.80x0.72
CYCN
CYCLERION THERAPEUTICS INC
NASDAQ
Biotechnology
$7.77M$2.870.99%-$197.00k-71.70x0.15
DMAC
DIAMEDICA THERAPEUTICS INC
NASDAQ
Biotechnology
$131.73M$3.47-5.19%-$19.13M-6.20x0.06
TRVI
TREVI THERAPEUTICS INC
NASDAQ
Biotechnology
$185.95M$2.64-8.97%-$33.30M-7.76x0.09
VTRS
VIATRIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$14.03B$11.810.77%$3.52B236.20x1.33
TCRX
TSCAN THERAPEUTICS INC
NASDAQ
Biotechnology
$383.54M$8.01-7.61%-$80.10M-5.89x0.80
CRBP
CORBUS PHARMACEUTICALS HOLDINGS INC
NASDAQ
Biotechnology
$453.01M$42.396.59%-$30.72M-6.11x0.30
YMAB
Y-MABS THERAPEUTICS INC
NASDAQ
Biotechnology
$597.24M$13.61-20.92%-$24.37M-27.78x0.24
PROF
PROFOUND MEDICAL CORP
NASDAQ
Medical Devices
$160.28M$7.501.21%-$23.73M-7.55x0.41
TTNP
TITAN PHARMACEUTICALS INC
NASDAQ
Biotechnology
$6.24M$6.821.19%-$5.46M-0.92x0.22
EVGN
EVOGENE LTD
NASDAQ
Biotechnology
$35.61M$0.70-0.14%-$20.34M-1.35x1.86
LABP
LANDOS BIOPHARMA INC
NASDAQ
Biotechnology
$69.21M$22.210.16%-$21.94M-6.34x0.20
ELVN
ENLIVEN THERAPEUTICS INC
NASDAQ
Biotechnology
$1.01B$24.49-0.85%-$70.98M-12.18x0.11

Healthcare Industries

IndustryStocks1d %1w %1m %1y %Zen ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
681-1.24%+1.30%-2.94%-20.18%6.71x5.96x+18.09%+3.22%-34.80%+82.14%Strong Buy
66-0.34%+0.76%-3.47%+1.36%39.98x4.23x-18.36%+6.29%+11.12%+10.97%Buy
17+0.16%+1.63%+2.45%+14.41%32.06x6.33x+33.59%+8.07%+14.17%+11.58%Buy
90-0.84%+0.63%-0.14%-5.38%22.88x2.16x+11.61%+3.20%+6.09%+32.87%Strong Buy
12-0.24%+1.90%+1.00%-0.13%19.67x2.95x+19.79%+6.08%+14.21%+15.24%Buy
60-2.44%-0.59%-6.83%-24.32%15.47x3.30x+6.90%+2.25%+5.23%+35.95%Buy
51-0.58%+1.45%-1.56%+8.89%44.51x4.34x-93.01%+6.67%+13.90%+16.48%Buy
154-3.77%-1.22%-5.24%-14.58%29.27x3.67x+7.55%+5.37%+7.93%+23.46%Buy
9-0.66%+0.01%-2.86%+30.63%26.33x108.04x-8.61%+3.42%+19.50%+11.44%Buy
56-1.42%+0.04%-2.15%-11.42%56.81x3.54x+11.42%+7.78%+10.24%+20.35%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -29.91% over the past year, underperforming other healthcare stocks by -21 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 18.4% from Cross Country Healthcare's current stock price of $16.47.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 6.9% over the past year, overperforming other healthcare stocks by 16 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 60.11% from Corcept Therapeutics's current stock price of $25.40.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Semler Scientific (NASDAQ:SMLR)


Semler Scientific (NASDAQ:SMLR) is the third best healthcare stock with a Zen Score of 65, which is 40 points higher than the healthcare sector average of 25. It passed 20 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -16.15% over the past year, underperforming other healthcare stocks by -7 percentage points.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 55.38%, which is 53 percentage points higher than the healthcare sector average of 2.82%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 14%, which is 11 percentage points higher than the healthcare sector average of 2.82%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.37%, which is 6 percentage points higher than the healthcare sector average of 2.82%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.29% in the last day, and up 0.67% over the last week. Treace Medical Concepts was the among the top losers in the healthcare sector, dropping -62.5% yesterday.

Treace Medical Concepts shares are trading lower after the company reported Q1 financial results and issued FY24 revenue guidance below estimates.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -29.84% in the past year. It has underperformed other stocks in the healthcare sector by -21 percentage points.

2. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -47.65% in the past year. It has underperformed other stocks in the healthcare sector by -39 percentage points.

3. Semler Scientific (NASDAQ:SMLR)


Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has dropped -16.15% in the past year. It has underperformed other stocks in the healthcare sector by -7 percentage points.

Are healthcare stocks a good buy now?

48.33% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 36.75% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.55x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.